Evidence map›Paper›PMID 33176280›Full record

ArticleAging2020

Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression.

Lei Wang, Haoran Li, Qingdong Qiao, Yukun Ge, Ling Ma, Qiang Wang

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. An Overview of Angiogenesis in Bladder Cancer.Current oncology reports · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lei WangDepartment of Urology, Xinxiang Central Hospital, Xinxiang, Henan, China.
Haoran LiSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.
Qingdong QiaoDepartment of Urology, Xinxiang Central Hospital, Xinxiang, Henan, China.
Yukun GeDepartment of Urology, Xinxiang Central Hospital, Xinxiang, Henan, China.
Ling MaDepartment of Urology, Xinxiang Central Hospital, Xinxiang, Henan, China.
Qiang WangDepartment of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xinxiang Central Hospital · CNCapital Medical University · CNXinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer (BC) is one of the most commonly diagnosed urologic carcinomas, with high recurrence and death rates. Circular RNAs (circRNAs) are a class of noncoding RNAs which are anomalously expressed in cancers and involved in the progression of cancers. In this study, we found that circSEMA5A was upregulated in BC tissues and cell lines. The overexpressed circSEMA5A was correlated with malignant characteristics of BC. In vitro data indicated that circSEMA5A promoted proliferation, suppressed apoptosis, facilitated migration, accelerated invasion, enhanced angiogenesis and promotes glycolysis of BC. Mechanistically, circSEMA5A served as a miRNA sponge for miR-330-5p to upregulates Enolase 1 (ENO1) expression and facilitated the activation of Akt and β-catenin signaling pathways. Then, we showed that circSEMA5A exerted its biological functions partially via miR-330-5p/ENO1 signaling. Moreover, circSEMA5A raised SEMA5A expression by recruiting EIF4A3 to enhance the mRNA stability of SEMA5A, and thereby accelerated BC angiogenesis. To sum up, circSEMA5A is upregulated in BC and facilitates BC progression by mediating miR-330-5p/ENO1 signaling and upregulating SEMA5A expression.

Indexed as

Biomarkers, TumorCell Line, TumorDisease ProgressionDNA-Binding ProteinsGene Expression Regulation, NeoplasticHumansMicroRNAsPhosphopyruvate HydrataseRNA, CircularSemaphorinsTumor Cells, CulturedTumor Suppressor ProteinsUp-RegulationUrinary Bladder NeoplasmsBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humanMicroRNAsMIRN330 microRNA, humanPhosphopyruvate HydrataseRNA, CircularSEMA5A protein, humanSemaphorinsTumor Suppressor Proteinsbladder cancercircular RNAEnolase 1miR-330-5pSEMA5A

Identifiers

PMID33176280
PMCPMC7695386
OpenAlexW3101709818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.